Related Experiment Video
Updated: Jul 12, 2026

Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
Cyclodextrin/carbopol micro-scale interpenetrating networks (ms-IPNs) for drug delivery
Carmen Rodriguez-Tenreiro1, Laura Diez-Bueno, Angel Concheiro
1Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Santiago de Compostela, 15782-Santiago de Compostela, Spain.
Abstract:
Cross-linking of hydroxypropyl-beta-cyclodextrin (HP beta CD) with ethyleneglycol diglycidylether (EGDE) in carbopol dispersions enabled the synthesis of cyclodextrin hydrogels with domains of interpenetrating acrylic microgels (micro-scale-IPNs) in a single step under mild conditions. As carbopol proportion increased, the hardness and compressibility of the ms-IPNs decreased, but their bioadhesion force and pH-responsiveness rose. Control HP beta CD hydrogel and ms-IPNs were loaded with estradiol and ketoconazole by immersion in drug suspensions, some of which were autoclaved to enhance (up to a 50%) drug/cyclodextrin affinity. ms-IPNs prepared with 0.8% or 1.0% carbopol showed the highest loading due to their greater swelling degree and, consequently, mesh size. The total loading of the ms-IPNs greatly exceeded (up to 200-fold) the amount dissolved in their aqueous phase, which highlights the main role of drug complexation with the cross-linked cyclodextrins. The affinity of the drug for HP beta CD sustained the release for several days; the rate being also dependent on carbopol content and on pH of the medium. Therefore, an adequate design of the HP beta CD/carbopol ms-IPNs provides a single material with tunable mechanical properties, in which the complexation ability of cyclodextrins is combined with the bioadhesive and pH-responsive properties of carbopol. The ms-IPNs are potentially useful as vehicles of relatively hydrophobic substances.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Rate-Programmed I
Oral Drug Delivery Systems: Delayed-Release Systems
Intrauterine Drug Delivery Systems
Transdermal Drug Delivery Systems

